Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Biol Psychiatry. 2010 Aug 25;68(9):811–817. doi: 10.1016/j.biopsych.2010.06.030

Table 1.

SardiNIA and BLSA meta-analysis of association results for trait depression.

Imputation quality (r2) Effect-allele frequency Effect size p-value

SNP Gene chr position Effect-allele SardiNIA BLSA SardiNIA BLSA SardiNIA BLSA SardiNIA BLSA Meta-analysis
rs12912233 RORA 15 59.05 T/C 0.54 0.96 .46 .46 0.15 0.09 1.8 ×10−6 6.1 ×10−2 6.3 ×10−7
rs8070473 SLFN12L 17 30.87 T/G 0.81 0.99 .32 .32 −0.16 −0.07 1.1 ×10−6 2.3 ×10−1 1.5 ×10−6
rs349475 CDH18* 5 19.48 T/C 0.66 0.86 .29 .29 0.18 0.02 2.4 ×10−7 7.3 ×10−1 2.4 ×10−6
rs12420464 EIF3F 11 7.97 T/G 0.37 GN .04 .04 −0.38 −0.08 1.3 ×10−6 3.8 ×10−1 3.3 ×10−6
rs8068353 SLFN12L 17 30.86 C/G 0.78 0.93 .32 .32 −0.15 −0.08 4.4 ×10−6 1.6 ×10−1 3.4 ×10−6
rs1927745 FAM155A* 13 106.58 A/G 0.66 GN .24 .24 −0.16 −0.06 3.5 ×10−6 2.4 ×10−1 4.7 ×10−6
rs10514585 CDH13 16 81.84 A/G GN 0.99 .31 .31 0.15 0.06 3.1 ×10−6 2.8 ×10−1 4.9 ×10−6
rs11009175 ITGB1* 10 33.33 A/G 0.86 0.96 .17 .17 0.16 0.16 4.2 ×10−5 2.3 ×10−2 5.4 ×10−6
rs17864092 GRM8 7 126.23 T/C 0.65 GN .90 .90 −0.17 −0.25 1.9 ×10−4 2.2 ×10−3 5.5 ×10−6
rs9634463 FAM155A* 13 106.57 T/C 0.89 0.90 .24 .24 −0.16 −0.05 2.5 ×10−6 3.7 ×10−1 5.7 ×10−6
rs7329003 FAM155A* 13 106.57 A/G GN 0.90 .75 .75 −0.16 −0.05 2.5 ×10−6 3.7 ×10−1 5.8 ×10−6
rs713548 FAM155A* 13 106.57 T/G 0.91 0.90 .25 .25 −0.16 −0.05 2.6 ×10−6 3.7 ×10−1 5.9 ×10−6
rs4775340 RORA 15 59.06 A/G 0.55 GN .43 .43 0.14 0.09 2.1 ×10−5 6.5 ×10−2 6.3 ×10−6
rs1449984 - 2 23.33 A/G 0.96 GN .72 .72 −0.15 −0.06 6.7 ×10−6 2.0 ×10−1 6.6 ×10−6
rs9301191 FAM155A* 13 106.57 T/C 0.85 0.90 .79 .79 −0.17 −0.05 2.9 ×10−6 3.9 ×10−1 7.1 ×10−6
rs8028646 RORA 15 59 A/T GN 0.99 .25 .25 −0.14 −0.15 1.6 ×10−4 4.6 ×10−3 7.2 ×10−6
rs1924397 FAM155A* 13 105.41 A/C 0.54 0.80 .96 .96 0.32 0.15 2.0 ×10−5 8.3 ×10−2 7.6 ×10−6
rs10744304 - 12 126.34 A/G 0.68 GN .63 .63 −0.15 −0.05 5.0 ×10−6 3.2 ×10−1 8.7 ×10−6
rs2017305 DDX21* 10 70.38 A/G 1.00 0.97 .92 .92 −0.22 −0.21 6.9 ×10−5 2.3 ×10−2 9.0 ×10−6
rs3740596 DDX50 10 70.34 A/G 1.00 0.97 .92 .92 −0.22 −0.20 6.8 ×10−5 2.6 ×10−2 9.5 ×10−6
rs12638201 CCR9 3 45.91 A/G 0.82 GN .14 .14 0.17 0.19 4.9 ×10−5 4.9 ×10−2 1.1 ×10−5
rs4796093 SLFN12L 17 30.87 A/G 0.89 GN .64 .64 −0.14 −0.06 9.3 ×10−6 2.6 ×10−1 1.2 ×10−5
rs4885589 - 13 78.45 T/C 0.86 0.96 .60 .60 0.10 0.18 1.1 ×10−3 2.4 ×10−4 1.3 ×10−5
rs1539163 DDX21 10 70.41 T/C 1.00 0.96 .08 .08 −0.21 −0.21 1.1 ×10−4 2.4 ×10−2 1.4 ×10−5
rs8023563 RORA 15 59 A/T GN 0.98 .76 .76 −0.13 −0.15 2.9 ×10−4 5.4 ×10−3 1.5 ×10−5
*

Nearest gene. GN = Genotyped. The first allele in the Effect-allele column is the reference allele for allele frequency and effect size direction.